Search
shopping
Search
Menu

Goal and Learning Outcomes

The goal of this course is to provide nurses, social workers, and other healthcare professionals in various settings with information on symptoms, diagnoses, and recommended treatment for the most prevalent mood disorders affecting children and adolescents. After taking this course, you should be able to:
  • Identify criteria for diagnoses of depressive and bipolar disorders in children and adolescents.
  • Identify signs and symptoms of depressive and bipolar disorders in children and adolescents.
  • Describe treatment options for mood disorders in children and adolescents.
  • Discuss the treatment benefits and risks for specific mood disorders in children and adolescents.
 
[DSM™ and DSM-5™ are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this course.]

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.